ADJUVANT PUBLICATIONS & ABSTRACTS
Adjuvant data
Evidence / Adjuvant
MINDACT & TAILORx Exploratory Comparison, Neven et al., SABCS 2023 Abstract
SABCS 2023, PO1-02-05 Authors: Patrick Neven et al.
Read MoreComparison of genomic test scores and CT Indications – SABCS 2023
SABCS 2023 Author: Vidal, Singh et al.
Read MorePROOFS-Registry: Trial in Progress, ESMO Breast 2023
ESMO Breast 2023, #120TiP Fischer et al.
Read MoreMINDACT: Outcomes of any adjuvant systemic treatment in ESBC
Annals of Oncology, Volume 33, Issue 3, March 2022, Pages 310-320 Authors: Lopes Cardozo et al.
Read MoreMINDACT Trial: Outcome of Patients with UltraLow Risk, JCO 2022
Journal of Clinical Oncology, Volume 40, Number 12, January 21, 2022 Authors: Audeh et al.
Read MoreWhole transcriptome analysis comparing HR+ HER2- breast cancer tumors from patients โค 50 years and > 50 years
PUBLICATION: ASCO 2021 ย Authors Cathy Graham1, Douglas K. Marks2, Nina DโAbreo2, Sami Diab3, Vijayakrishna K. Gadi4, Midas M. Kuilman5, Andrea Menicucci6, Amy M. Truitt6, Shiyu Wang6, Patricia Dauer6, William Audeh6, FLEX Investigatorsโ Group8 Background Recent prospective clinical trials have demonstrated a differential chemotherapy effect based on age (โค Read More
MammaPrint and BluePrint as prognostic indicators for elderly patients with early-stage breast cancer
PUBLICATION: SABCS 2020 AUTHORS: Peter W. Blumencranz, Mehran Habibi, Lisa Blumencranz, Andrea Menicucci, Shiyu Wang, Amy Truitt, William Audeh, Jolanta L. Baginski, Steven Shivers, Geza Acs, Charles E. Cox, MINT Investigators Group. Background: Elderly breast cancer (BC) patients are an understudied population, with limited evidence regarding treatment options and Read More